Tempus is a technology company that is revolutionizing healthcare by applying artificial intelligence (AI) to various fields, including oncology, cardiology, and infectious diseases. The company was founded in 2015 by Eric Lefkofsky, who also co-founded Groupon, and has since raised over $600 million in funding.
The company’s mission is to improve patient outcomes by providing physicians with data-driven insights and personalized treatment options. To achieve this, Tempus has developed a platform that aggregates and analyzes large amounts of clinical and genomic data from patients.
One of the key areas where Tempus is making a significant impact is in oncology.